These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 33452837

  • 1. Is implant surgery a risk factor for osteonecrosis of the jaw in older adult patients with osteoporosis? A national cohort propensity score-matched study.
    Ryu JI, Kim HY, Kwon YD.
    Clin Oral Implants Res; 2021 Apr; 32(4):437-447. PubMed ID: 33452837
    [Abstract] [Full Text] [Related]

  • 2. Incidence of and risk for osteonecrosis of the jaw in Korean osteoporosis patients treated with bisphosphonates: A nationwide cohort-study.
    Kim SH, Lee YK, Kim TY, Ha YC, Jang S, Kim HY.
    Bone; 2021 Feb; 143():115650. PubMed ID: 32956854
    [Abstract] [Full Text] [Related]

  • 3. No increased risk of osteonecrosis of the jaw in osteoporotic patients with dental implants: a nationwide cohort study.
    Park JH, Lee JR, Lee H, Lee HJ, Kim JW.
    Clin Oral Investig; 2024 Jan 09; 28(1):83. PubMed ID: 38195947
    [Abstract] [Full Text] [Related]

  • 4. Risk comparison of osteonecrosis of the jaw in osteoporotic patients treated with bisphosphonates vs. denosumab: a multi-institutional retrospective cohort study in Taiwan.
    Liu FC, Luk KC, Chen YC.
    Osteoporos Int; 2023 Oct 09; 34(10):1729-1737. PubMed ID: 37326685
    [Abstract] [Full Text] [Related]

  • 5. The national-scale cohort study on bisphosphonate-related osteonecrosis of the jaw in Taiwan.
    Yuh DY, Chang TH, Huang RY, Chien WC, Lin FG, Fu E.
    J Dent; 2014 Oct 09; 42(10):1343-52. PubMed ID: 24907558
    [Abstract] [Full Text] [Related]

  • 6. Medication-Related Osteonecrosis of the Jaw Around Dental Implants: Implant Surgery-Triggered or Implant Presence-Triggered Osteonecrosis?
    Giovannacci I, Meleti M, Manfredi M, Mortellaro C, Greco Lucchina A, Bonanini M, Vescovi P.
    J Craniofac Surg; 2016 May 09; 27(3):697-701. PubMed ID: 27092912
    [Abstract] [Full Text] [Related]

  • 7. Impact of bisphosphonate-related osteonecrosis of the jaw on osteoporotic patients after dental extraction: a population-based cohort study.
    Huang YF, Chang CT, Muo CH, Tsai CH, Shen YF, Wu CZ.
    PLoS One; 2015 May 09; 10(4):e0120756. PubMed ID: 25880208
    [Abstract] [Full Text] [Related]

  • 8. Gradual, but Not Sudden, Dose-Dependent Increase of ONJ Risk With Bisphosphonate Exposure: A Nationwide Cohort Study in Women With Osteoporosis.
    Park JH, Kwoen MJ, Lee JR, Kim KS, Lee HJ, Kim JW, Lee H.
    Front Endocrinol (Lausanne); 2021 May 09; 12():774820. PubMed ID: 34956086
    [Abstract] [Full Text] [Related]

  • 9. Incidence and risk of osteonecrosis of the jaw among the Taiwan osteoporosis population.
    Lin TC, Yang CY, Kao Yang YH, Lin SJ.
    Osteoporos Int; 2014 May 09; 25(5):1503-11. PubMed ID: 24515577
    [Abstract] [Full Text] [Related]

  • 10. A Large National Cohort Study of the Association between Bisphosphonates and Osteonecrosis of the Jaw in Patients with Osteoporosis: A Nested Case-control Study.
    Kwon JW, Park EJ, Jung SY, Sohn HS, Ryu H, Suh HS.
    J Dent Res; 2015 Sep 09; 94(9 Suppl):212S-9S. PubMed ID: 26001708
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Risk of Osteonecrosis of the Jaw Under Denosumab Compared to Bisphosphonates in Patients With Osteoporosis.
    Everts-Graber J, Lehmann D, Burkard JP, Schaller B, Gahl B, Häuselmann H, Studer U, Ziswiler HR, Reichenbach S, Lehmann T.
    J Bone Miner Res; 2022 Feb 09; 37(2):340-348. PubMed ID: 34787342
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dental extraction as a risk factor for bisphosphonate related osteonecrosis of the jaw in cancer patients: an update.
    Utreja A, Almas K, Javed F.
    Odontostomatol Trop; 2013 Jun 09; 36(142):38-46. PubMed ID: 24073539
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of dental implants as a risk factor for the development of bisphosphonate-related osteonecrosis of the jaw in breast cancer patients.
    Matsuo A, Hamada H, Takahashi H, Okamoto A, Kaise H, Chikazu D.
    Odontology; 2016 Sep 09; 104(3):363-71. PubMed ID: 25956267
    [Abstract] [Full Text] [Related]

  • 17. Survival of dental implants among post-menopausal female dental school patients taking oral bisphosphonates: a retrospective study.
    Famili P, Quigley S, Mosher T.
    Compend Contin Educ Dent; 2011 Sep 09; 32(6):E106-9. PubMed ID: 23738968
    [Abstract] [Full Text] [Related]

  • 18. Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment: a nationwide user-only cohort study including over 60,000 alendronate users.
    Eiken PA, Prieto-Alhambra D, Eastell R, Abrahamsen B.
    Osteoporos Int; 2017 Oct 09; 28(10):2921-2928. PubMed ID: 28664276
    [Abstract] [Full Text] [Related]

  • 19. Assessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fractures.
    Lapi F, Cipriani F, Caputi AP, Corrao G, Vaccheri A, Sturkenboom MC, Di Bari M, Gregori D, Carle F, Staniscia T, Vestri A, Brandi M, Fusco V, Campisi G, Mazzaglia G, Bisphosphonates Efficacy-Safety Tradeoff (BEST) study group.
    Osteoporos Int; 2013 Feb 09; 24(2):697-705. PubMed ID: 22618266
    [Abstract] [Full Text] [Related]

  • 20. Defining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: prior work and current challenges.
    Solomon DH, Mercer E, Woo SB, Avorn J, Schneeweiss S, Treister N.
    Osteoporos Int; 2013 Jan 09; 24(1):237-44. PubMed ID: 22707065
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.